A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, HS Kim, K Kim, WS Kim… - Bone marrow …, 2002 - nature.com
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …
被引用次数：110 相关文章

[引用][C] A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim, K Kim… - Bone Marrow …, 2002 - cir.nii.ac.jp
A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive
disease after hematopoietic stem cell transplantation | CiNii Research CiNii 国立情報学 …

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim… - Bone marrow …, 2002 - pubmed.ncbi.nlm.nih.gov
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim… - Bone Marrow …, 2002 - scholarworks.bwise.kr
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

A randomized trial of heparin plus ursodiol vsheparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim, K Kim… - Bone Marrow …, 2002 - go.gale.com
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.

SH Park, MH Lee, H Lee, HS Kim, K Kim… - Bone Marrow …, 2002 - europepmc.org
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

[引用][C] A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH PARK, MH LEE, K PARK, CH PARK… - Bone marrow …, 2002 - pascal-francis.inist.fr
A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive
disease after hematopoietic stem cell transplantation CNRS Inist Pascal-Francis CNRS …

[引用][C] A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.

SH Park, MH Lee, HS Kim, K Kim… - Bone Marrow …, 2002 - search.ebscohost.com
Post-transplant complications A randomized trial of heparin plus ursodiol vs heparin alone to
prevent hepatic veno-occlusive dis Page 1 Bone Marrow Transplantation 12002) 29, 137-143 …

A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim… - Bone Marrow …, 2002 - snucm.elsevierpure.com
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

[引用][C] A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim… - Bone Marrow …, 2002 - Nature Publishing Group